Endpoints News 生物医药· Ayisha Sharma·· 2026-09-29AI 评分38
SK pharmteco 宣布投资超 2 亿美元以扩展 CDMO 能力
SK pharmteco unveils $200M+ investment to expand CDMO capabilities
AI 导读
SK pharmteco 计划在未来五年内投入至少 2 亿美元,用于建设其开发与制造基础设施,以扩展 CDMO 能力。该投资决策旨在加强公司在此领域的业务布局,文章指出此预期正在推进中。
正文
SK pharmteco plans to spend at least $200 million on building out its development and manufacturing infrastructure over the next five years, which is expected …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
来源:Endpoints News 生物医药 · endpoints.news